Catherine A Barrett

Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation.

B. Portmann, R. D. de Man, R. Williams, 2001, Journal of hepatology.

Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR). The CAESAR Coordinating Committee.

D. Cooper, G. Dore, L. Goh, 1999, The Journal of infectious diseases.